MedTrace Logo

Dorsal Wrist Ganglia; Aspiration Alone vs Aspiration and Injection of Platelet Rich Plasma

NCT03408808 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2021-06-24

Study results available
· View outcomes & findings →

Summary

Study to examine the efficacy of Platelet Rich Plasma (PRP) to reduce recurrence in dorsal wrist ganglia (DWG). We will compare aspiration alone and aspiration with injection of PRP.

We plan to recruit a maximum of 200 patients. We will assess the efficacy by contacting the patients by email or telephone at 6 weeks and 12 months. They will be asked to complete a questionnaire and a Patient Evaluated Measure score (PEMS). Adverse events will be screened for/ managed by a telephone call +/- review as necessary between 7 and 14 days.

Conditions

  • Ganglion of Wrist

Interventions

PROCEDURE

Platelet rich plasma

Aspiration of ganglion and injection with platelet rich plasma.

PROCEDURE

Aspiration alone

Aspiration of the ganglion

Sponsors & Collaborators

  • NHS Grampian

    collaborator OTHER_GOV

  • Arthrex, Inc.

    collaborator INDUSTRY

  • University of Aberdeen

    lead OTHER

Principal Investigators

  • Katharine Hamlin, MBChB · NHS Grampian

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-05
Primary Completion
2021-02-05
Completion
2021-02-05

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03408808 on ClinicalTrials.gov